Cleerly ISCHEMIA vs CT Cardiomegaly
AI Verdict
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you require a comprehensive, non-invasive assessment of coronary artery disease, including the likelihood of vessel-level ischemia and detailed plaque characterization from CCTA scans. This tool is ideal for physicians needing advanced insights into coronary stenosis severity and functional impact to guide personalized diagnosis and treatment strategies.
View Cleerly ISCHEMIA →Choose CT Cardiomegaly if…
Choose CT Cardiomegaly if your primary need is automated, quantitative measurement of the cardiothoracic ratio from CT chest images for efficient detection and monitoring of cardiomegaly. This command-line software is best suited for workflows requiring a rapid and objective assessment of heart size relative to the thoracic cavity.
View CT Cardiomegaly →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | CT Cardiomegaly |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Web-based solution | Docker Container (Ubuntu 20.04), command-line software |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cleerly ISCHEMIACleerly ISCHEMIA operates as a web-based platform with comprehensive interactive reports and integrates with PowerScribe via API, indicating a user-friendly graphical interface and seamless workflow integration. In contrast, CT Cardiomegaly is a command-line software, which is generally less intuitive and requires more technical proficiency for most clinical users.
Clinical Value
Cleerly ISCHEMIACleerly ISCHEMIA offers a comprehensive analysis of CCTA scans, including non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood, and coronary plaque characterization, providing deep insights for personalized diagnosis and treatment planning for heart disease. It has demonstrated robust diagnostic accuracy and prognostic utility in clinical trials. While CT Cardiomegaly accurately measures cardiothoracic ratio, its clinical scope is narrower, providing a single quantitative metric for cardiomegaly detection.
Pricing & Value
Cleerly ISCHEMIABoth tools require direct contact for pricing, making a direct cost comparison difficult. However, Cleerly ISCHEMIA is billable under a Category I CPTu00ae Code 75580 for non-invasive FFR estimation, which provides a clear reimbursement pathway for providers and potentially reduces financial uncertainty and overall care costs by guiding appropriate interventions. No such specific reimbursement information is available for CT Cardiomegaly.
Enterprise Readiness
Cleerly ISCHEMIABoth tools are FDA-cleared, HIPAA compliant, and offer BAAs. Cleerly ISCHEMIA's web-based platform and integration with PowerScribe via API suggest a more straightforward and less resource-intensive integration into existing clinical enterprise workflows. CT Cardiomegaly's deployment as a Docker container with a command-line interface, while robust for IT, may require more custom development for seamless clinical adoption.
Innovation
Cleerly ISCHEMIACleerly ISCHEMIA's non-invasive estimation of fractional flow reserve (FFR) and comprehensive coronary plaque characterization from CCTA scans represents a significant innovation in cardiology, providing functional assessment that traditionally required invasive procedures. CT Cardiomegaly, while utilizing machine learning for automated cardiothoracic ratio measurement, applies AI to an existing, well-established metric, making its innovation less groundbreaking in comparison.
Support & Docs
TieNeither the provided structured facts nor the web search results offer sufficient specific information regarding the availability, quality, or scope of customer support and documentation for either Cleerly ISCHEMIA or Innolitics CT Cardiomegaly. Therefore, it is not possible to distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | CT Cardiomegaly |
|---|---|---|
| Name | Cleerly ISCHEMIA | CT Cardiomegaly |
| Company | Cleerly | Innolitics |
| Description | Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. | Innolitics' CT Cardiomegaly is an FDA-cleared AI-powered command-line software that automatically measures cardiothoracic ratio from CT chest images, assisting physicians in cardiomegaly detection with quantitative data. |
| Key Features | AI-enabled CCTA analysis, Non-invasive fractional flow reserve (FFR) estimation, Vessel-level ischemia likelihood determination, Coronary plaque characterization (volume, type, location), Stenosis severity assessment, 3D digital models of coronary arteries, Comprehensive interactive web-based reports, Integration with PowerScribe via API | Automatic cardiothoracic ratio measurement, Machine learning algorithms for segmentation, Segmentation of heart and thoracic cavity, Calculates linear and area-based cardiothoracic ratios, Outputs PDF and JSON reports, Command-line software tool, Non-adaptive machine learning using MONAI framework, Validated against manual measurements by board-certified radiologists |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Radiology & Imaging AI |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and CT Cardiomegaly.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly ISCHEMIA or CT Cardiomegaly
Backers
Who funded each tool's parent company.